Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate Bennett

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 15, 2015
Immediate remote ischemic postconditioning after hypoxia ischemia in piglets protects cerebral white matter but not grey matterMojgan Ezzati, Alan Bainbridge, Kevin D Broad, et al.
BMJ Open|January 18, 2021
COVID-19-related social support service closures and mental well-being in older adults and those affected by dementia: a UK longitudinal surveyClarissa Giebel, Daniel Pulford, Claudia Cooper, et al.
International Journal of Geriatric Psychiatry|September 18, 2020
A UK survey of COVID-19 related social support closures and their effects on older people, people with dementia, and carersClarissa Giebel, Kathryn Lord, Claudia Cooper, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|January 12, 2022
Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): Protocol for a randomized controlled trialJonathan G Best, Liz Arram, Norin Ahmed, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 8, 2024
Unlocking the diagnostic power of plasma extracellular vesicle miR-200 family in pancreatic ductal adenocarcinomaDaniel S K Liu, Jisce R Puik, Bhavik Y Patel, et al.
Lancet (London, England)|November 4, 2024
Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trialDavid J Werring, Hakim-Moulay Dehbi, Norin Ahmed, et al.
Stroke|April 1, 2026
Early Versus Delayed Anticoagulation in Acute Ischemic Stroke According to Atrial Fibrillation Subtype and Time of Diagnosis: Subgroup Analysis of the OPTIMAS Randomized Controlled TrialJames Lyon, Philip S Nash, Norin Ahmed, et al.
Stroke|May 22, 2025
Anticoagulation Timing in Acute Stroke With Atrial Fibrillation According to Chronic Kidney Disease: The OPTIMAS TrialPhilip S Nash, Hakim-Moulay Dehbi, Norin Ahmed, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 30, 2026
Early Versus Delayed Anticoagulation in Acute Ischaemic Stroke with Atrial Fibrillation According to Infarct Volume and Location: a Prespecified Subgroup Analysis of the OPTIMAS Randomised Controlled TrialPhilip S Nash, Jonathan Best, James Lyon, et al.
Nature Communications|September 15, 2021
New-onset IgG autoantibodies in hospitalized patients with COVID-19Sarah Esther Chang, Allan Feng, Wenzhao Meng, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 15, 2015
Immediate remote ischemic postconditioning after hypoxia ischemia in piglets protects cerebral white matter but not grey matterMojgan Ezzati, Alan Bainbridge, Kevin D Broad, et al.
BMJ Open|January 18, 2021
COVID-19-related social support service closures and mental well-being in older adults and those affected by dementia: a UK longitudinal surveyClarissa Giebel, Daniel Pulford, Claudia Cooper, et al.
International Journal of Geriatric Psychiatry|September 18, 2020
A UK survey of COVID-19 related social support closures and their effects on older people, people with dementia, and carersClarissa Giebel, Kathryn Lord, Claudia Cooper, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|January 12, 2022
Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): Protocol for a randomized controlled trialJonathan G Best, Liz Arram, Norin Ahmed, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 8, 2024
Unlocking the diagnostic power of plasma extracellular vesicle miR-200 family in pancreatic ductal adenocarcinomaDaniel S K Liu, Jisce R Puik, Bhavik Y Patel, et al.
Lancet (London, England)|November 4, 2024
Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trialDavid J Werring, Hakim-Moulay Dehbi, Norin Ahmed, et al.
Stroke|April 1, 2026
Early Versus Delayed Anticoagulation in Acute Ischemic Stroke According to Atrial Fibrillation Subtype and Time of Diagnosis: Subgroup Analysis of the OPTIMAS Randomized Controlled TrialJames Lyon, Philip S Nash, Norin Ahmed, et al.
Stroke|May 22, 2025
Anticoagulation Timing in Acute Stroke With Atrial Fibrillation According to Chronic Kidney Disease: The OPTIMAS TrialPhilip S Nash, Hakim-Moulay Dehbi, Norin Ahmed, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 30, 2026
Early Versus Delayed Anticoagulation in Acute Ischaemic Stroke with Atrial Fibrillation According to Infarct Volume and Location: a Prespecified Subgroup Analysis of the OPTIMAS Randomised Controlled TrialPhilip S Nash, Jonathan Best, James Lyon, et al.
Nature Communications|September 15, 2021
New-onset IgG autoantibodies in hospitalized patients with COVID-19Sarah Esther Chang, Allan Feng, Wenzhao Meng, et al.
Pageof 8